13F HOLDINGS REPORT
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000950159-23-000173
Total Value
$4.49B
Positions
106
Other Managers
1
Confidential Omitted
No
Holdings (106)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NUVALENT INC | NUVL | 19,991,024 | $521.6M | 11.63% |
| 2 | GLAUKOS CORP | GKOS | 271,752,000 | $336.2M | 7.50% |
| 3 | NEUROCRINE BIOSCIENCES INC | NBIX | 1,744,714 | $176.6M | 3.94% |
| 4 | CATALYST PHARMACEUTICALS INC | CPRX | 10,355,099 | $171.7M | 3.83% |
| 5 | NATERA INC | NTRA | 101,042,000 | $164.1M | 3.66% |
| 6 | VIATRIS INC | VTRS | 16,935,997 | $162.9M | 3.63% |
| 7 | ADAPTHEALTH CORP | AHCO | 10,594,914 | $131.7M | 2.94% |
| 8 | TABULA RASA HEALTHCARE INC | 873379AA9 | 144,516,000 | $117.3M | 2.61% |
| 9 | IONIS PHARMACEUTICALS INC | IONS | 127,800,000 | $116.9M | 2.61% |
| 10 | AMEDISYS INC | 023436108 | 1,483,179 | $109.1M | 2.43% |
| 11 | BROOKDALE SR LIVING INC | 112463AC8 | 145,955,000 | $104.8M | 2.34% |
| 12 | INTERCEPT PHARMACEUTICALS IN | INTR | 98,354,000 | $101.2M | 2.26% |
| 13 | ACCOLADE INC | 00437EAB8 | 122,598,000 | $96.6M | 2.15% |
| 14 | APELLIS PHARMACEUTICALS INC | APLS | 51,793,000 | $96.0M | 2.14% |
| 15 | INSMED INC | INSM | 103,200,000 | $94.4M | 2.10% |
| 16 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 5,218,638 | $80.6M | 1.80% |
| 17 | LARIMAR THERAPEUTICS INC | LRMR | 16,941,357 | $76.7M | 1.71% |
| 18 | PACIRA BIOSCIENCES INC | PCRX | 81,600,000 | $75.0M | 1.67% |
| 19 | ARS PHARMACEUTICALS INC | SPRY | 11,077,927 | $72.1M | 1.61% |
| 20 | CENTENE CORP DEL | CNC | 1,075,000 | $68.0M | 1.51% |
| 21 | SILK RD MED INC | 82710M100 | 1,725,640 | $67.5M | 1.51% |
| 22 | GUARDANT HEALTH INC | GH | 89,036,000 | $59.6M | 1.33% |
| 23 | AMYLYX PHARMACEUTICALS INC | AMLX | 1,984,333 | $58.2M | 1.30% |
| 24 | NANOSTRING TECHNOLOGIES INC | 63009RAD1 | 70,204,000 | $58.0M | 1.29% |
| 25 | INTERCEPT PHARMACEUTICALS IN | INTR | 57,791,000 | $57.0M | 1.27% |
| 26 | OWENS & MINOR INC NEW | 690732102 | 3,867,455 | $56.3M | 1.25% |
| 27 | MIRUM PHARMACEUTICALS INC | MIRM | 2,032,335 | $48.8M | 1.09% |
| 28 | BROOKDALE SR LIVING INC | 112463104 | 16,406,047 | $48.4M | 1.08% |
| 29 | ENHABIT INC | EHAB | 3,398,746 | $47.3M | 1.05% |
| 30 | HILLEVAX INC | 43157M102 | 2,833,690 | $46.8M | 1.04% |
| 31 | LIVONGO HEALTH INC | 539183AA1 | 50,000,000 | $44.4M | 0.99% |
| 32 | MERUS N V | N5749R100 | 2,380,438 | $43.8M | 0.98% |
| 33 | CAREMAX INC | 14171W103 | 15,861,090 | $42.3M | 0.94% |
| 34 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 1,579,349 | $40.7M | 0.91% |
| 35 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 734,000 | $39.7M | 0.89% |
| 36 | IVERIC BIO INC | 46583P102 | 1,504,578 | $36.6M | 0.82% |
| 37 | PTC THERAPEUTICS INC | PTCT | 32,000,000 | $36.3M | 0.81% |
| 38 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,535,723 | $33.6M | 0.75% |
| 39 | COGENT BIOSCIENCES INC | COGT | 2,966,345 | $32.0M | 0.71% |
| 40 | EVOLUS INC | EOLS | 3,569,000 | $30.2M | 0.67% |
| 41 | KURA ONCOLOGY INC | KURA | 2,383,000 | $29.1M | 0.65% |
| 42 | HEALTH CATALYST INC | HCAT | 30,000,000 | $27.2M | 0.61% |
| 43 | PULMONX CORP | LUNG | 2,402,704 | $26.9M | 0.60% |
| 44 | DOCGO INC | DCGO | 3,059,000 | $26.5M | 0.59% |
| 45 | EDGEWISE THERAPEUTICS INC | EWTX | 3,933,137 | $26.2M | 0.58% |
| 46 | BELLUS HEALTH INC NEW | 07987C204 | 3,581,000 | $25.8M | 0.57% |
| 47 | KRYSTAL BIOTECH INC | KRYS | 311,949 | $25.0M | 0.56% |
| 48 | TERNS PHARMACEUTICALS INC | TERN | 2,059,421 | $24.4M | 0.54% |
| 49 | IDEAYA BIOSCIENCES INC | IDYA | 1,743,628 | $23.9M | 0.53% |
| 50 | BIOCRYST PHARMACEUTICALS INC | BCRX | 2,765,000 | $23.1M | 0.51% |
| 51 | GENEDX HOLDINGS CORP | 81663L101 | 57,192,101 | $20.9M | 0.47% |
| 52 | VENTYX BIOSCIENCES INC | 92332V107 | 617,000 | $20.7M | 0.46% |
| 53 | VIGIL NEUROSCIENCE INC | 92673K108 | 2,052,010 | $20.1M | 0.45% |
| 54 | VIKING THERAPEUTICS INC | VKTX | 1,125,000 | $18.7M | 0.42% |
| 55 | GUARDANT HEALTH INC | GH | 778,999 | $18.3M | 0.41% |
| 56 | REVOLUTION MEDICINES INC | RVMDW | 829,737 | $18.0M | 0.40% |
| 57 | XERIS BIOPHARMA HOLDINGS INC | XERS | 18,000,000 | $17.3M | 0.39% |
| 58 | ALPHATEC HLDGS INC | ATEC | 1,046,791 | $16.3M | 0.36% |
| 59 | DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | 1,600,000 | $16.2M | 0.36% |
| 60 | OAK STR HEALTH INC | 67181AAB3 | 15,403,000 | $15.2M | 0.34% |
| 61 | TARSUS PHARMACEUTICALS INC | TARS | 1,156,032 | $14.5M | 0.32% |
| 62 | INVITAE CORP | 46185LAB9 | 15,711,000 | $14.1M | 0.32% |
| 63 | DENALI THERAPEUTICS INC | DNLI | 594,989 | $13.7M | 0.31% |
| 64 | ANAPTYSBIO INC | ANABV | 613,000 | $13.3M | 0.30% |
| 65 | ROIVANT SCIENCES LTD | ROIV | 1,750,000 | $12.9M | 0.29% |
| 66 | INVITAE CORP | 46185L103 | 9,274,707 | $12.5M | 0.28% |
| 67 | MINERALYS THERAPEUTICS INC | MLYS | 729,021 | $11.4M | 0.25% |
| 68 | INSMED INC | INSM | 658,546 | $11.2M | 0.25% |
| 69 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,831,607 | $11.2M | 0.25% |
| 70 | VAXCYTE INC | PCVX | 295,000 | $11.1M | 0.25% |
| 71 | PRIME MEDICINE INC | PRME | 885,314 | $10.9M | 0.24% |
| 72 | FUSION PHARMACEUTICALS INC | 36118A100 | 2,823,000 | $10.6M | 0.24% |
| 73 | VERA THERAPEUTICS INC | VERA | 1,300,000 | $10.1M | 0.22% |
| 74 | NUVATION BIO INC | NUVB | 5,854,860 | $9.7M | 0.22% |
| 75 | STRUCTURE THERAPEUTICS INC | GPCR | 375,000 | $8.9M | 0.20% |
| 76 | SINGULAR GENOMICS SYSTEMS IN | 82933R100 | 6,450,871 | $7.8M | 0.17% |
| 77 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 650,000 | $7.5M | 0.17% |
| 78 | BLUEBIRD BIO INC | 09609G100 | 2,175,000 | $6.9M | 0.15% |
| 79 | ALECTOR INC | ALEC | 1,055,192 | $6.5M | 0.15% |
| 80 | CASTLE BIOSCIENCES INC | CSTL | 272,135 | $6.2M | 0.14% |
| 81 | NEOGENOMICS INC | NEO | 6,500,000 | $6.0M | 0.13% |
| 82 | FOGHORN THERAPEUTICS INC | FHTX | 777,525 | $4.8M | 0.11% |
| 83 | CABALETTA BIO INC | CABA | 464,252 | $3.8M | 0.09% |
| 84 | NYXOAH S A | NYXH | 455,262 | $3.4M | 0.08% |
| 85 | ABEONA THERAPEUTICS INC | ABEO | 869,565 | $2.5M | 0.05% |
| 86 | THE ONCOLOGY INSTITUTE INC | 68236X100 | 3,360,052 | $2.3M | 0.05% |
| 87 | ANNEXON INC | ANNX | 583,913 | $2.2M | 0.05% |
| 88 | ACUTUS MED INC | 005111109 | 2,651,667 | $2.0M | 0.04% |
| 89 | RAIN ONCOLOGY INC | 75082Q105 | 227,393 | $2.0M | 0.04% |
| 90 | ORCHARD THERAPEUTICS PLC | 68570P200 | 316,169 | $1.7M | 0.04% |
| 91 | ROIVANT SCIENCES LTD | ROIV | 1,000,000 | $1.5M | 0.03% |
| 92 | CAREMAX INC | 14171W111 | 672,000 | $323,770 | 0.01% |
| 93 | MEDAVAIL HOLDINGS INC | 58406B103 | 836,626 | $239,777 | 0.01% |
| 94 | BUTTERFLY NETWORK INC | BFLY | 733,333 | $195,140 | 0.00% |
| 95 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 92,787 | $170,728 | 0.00% |
| 96 | THE ONCOLOGY INSTITUTE INC | 68236X118 | 1,250,000 | $81,375 | 0.00% |
| 97 | QUANTUM SI INC | QSIAW | 333,333 | $50,000 | 0.00% |
| 98 | SOMALOGIC INC | 83444K113 | 120,000 | $36,000 | 0.00% |
| 99 | MEDTECH ACQUISITION CORP | 58507N113 | 333,333 | $20,467 | 0.00% |
| 100 | NUVATION BIO INC | NUVB | 166,666 | $20,000 | 0.00% |
| 101 | SENIOR CONNECT ACQUISITN COR | SNIRF | 500,000 | $19,550 | 0.00% |
| 102 | SURROZEN INC | SRZNW | 166,666 | $16,667 | 0.00% |
| 103 | SIENTRA INC | 82621J204 | 10,000 | $15,400 | 0.00% |
| 104 | EUCRATES BIOMEDICAL ACQU COR | G3141W122 | 333,333 | $13,500 | 0.00% |
| 105 | EUCRATES BIOMEDICAL ACQU COR | G3141W114 | 1 | $10 | 0.00% |
| 106 | MEDTECH ACQUISITION CORP | 58507N204 | 1 | $10 | 0.00% |